Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

TELA Bio

TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.

TELA Bio
Finance

TELA Bio Reports Q3 2023 Results: 11th Consecutive Quarter of 35% YoY Growth

November 13, 2023November 12, 2023 - by Timothy Alexander

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading player in the biotechnology industry, recently reported its financial results for the third quarter of 2023, marking an impressive 11th …

TELA Bio Reports Q3 2023 Results: 11th Consecutive Quarter of 35% YoY Growth Read More

Posts pagination

Previous 1 … 3 4

Trending News

  • DMVA Urges Veterans to Secure Missing Military Records to Access Earned Benefits

  • Gwynedd Mercy University Launches Compassionate Care Collaborative to Tackle Healthcare Workforce Gaps

  • ARPA-H Launches Ambitious Program to Regenerate Brain Tissue and Restore Neurological Function

  • Teens Busted After Dawn Dunkin’ Heist in Bear — Cash Stolen, All Four Arrested

  • HHS Reverses Clinton-Era Policy, Restricts Federal Benefits to U.S. Citizens

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

DD-214 Military Paperwork

DMVA Urges Veterans to Secure Missing Military Records to Access Earned Benefits

July 14, 2025July 14, 2025

Arrested

Teens Busted After Dawn Dunkin’ Heist in Bear — Cash Stolen, All Four Arrested

July 14, 2025July 14, 2025

US Department of Health and Human Services (HHS)

HHS Reverses Clinton-Era Policy, Restricts Federal Benefits to U.S. Citizens

July 14, 2025July 13, 2025

Copyright © 2025 MyChesCo.